Deep Track Capital, LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Deep Track Capital, LP disclosed 56 US equity positions worth $3.6bn in its Q3 2025 13F filing. The largest position was GH at 7.2% of the reported book, followed by IONS and CYTK. Against the Q2 2025 filing, it opened 9 new positions, added to 12 and reduced 17 among the top 50 holdings.
What did Deep Track Capital, LP own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | Healthcare | 7.2% | $259.5m | 4,154,086 | -2% | reduced |
| 2 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 7.0% | $249.1m | 3,808,144 | -22% | reduced |
| 3 | CYTK CYTOKINETICS INC | Healthcare | 6.6% | $236.3m | 4,300,000 | 18% | added |
| 4 | AKERO THERAPEUTICS INC | 5.3% | $190.0m | 4,000,978 | 31% | added | |
| 5 | APLSUSD APELLIS PHARMACEUTICALS INC | 5.1% | $181.0m | 8,000,382 | 14% | added | |
| 6 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 5.0% | $178.3m | 3,000,000 | 71% | added |
| 7 | IMVT IMMUNOVANT INC | Healthcare | 4.4% | $156.8m | 9,728,845 | 2% | added |
| 8 | DVAX DYNAVAX TECHNOLOGIES CORP | 4.4% | $156.2m | 15,726,349 | -12% | reduced | |
| 9 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.9% | $139.5m | 11,932,137 | -17% | reduced |
| 10 | ETNBGBP 89BIO INC | 3.8% | $137.5m | 9,356,171 | -2% | reduced | |
| 11 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 3.3% | $118.0m | 4,215,811 | -18% | reduced |
| 12 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 3.2% | $116.1m | 5,380,449 | 0% | held |
| 13 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 3.2% | $114.0m | 1,715,691 | -47% | reduced |
| 14 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 3.1% | $109.3m | 900,000 | 12% | added |
| 15 | PCVX VAXCYTE INC | Healthcare | 3.0% | $108.1m | 3,000,000 | 40% | added |
| 16 | MAZE MAZE THERAPEUTICS INC | 2.9% | $102.4m | 3,948,910 | 0% | held | |
| 17 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 1.8% | $65.4m | 1,800,000 | 0% | held |
| 18 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.7% | $62.3m | 1,200,000 | 33% | added |
| 19 | GERN GERON CORP | Healthcare | 1.6% | $56.3m | 41,096,522 | -4% | reduced |
| 20 | 430 TERNS PHARMACEUTICALS INC | 1.6% | $56.3m | 7,495,000 | 0% | held | |
| 21 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.6% | $56.0m | 6,057,024 | -0% | held |
| 22 | MBX MBX BIOSCIENCES INC | Healthcare | 1.5% | $55.1m | 3,150,000 | 44% | added |
| 23 | EXK EXACT SCIENCES CORP | Basic Materials | 1.5% | $54.7m | 1,000,000 | – | new |
| 24 | LB PHARMACEUTICALS INC | 1.5% | $52.9m | 3,352,804 | – | new | |
| 25 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.4% | $51.7m | 2,000,000 | 0% | held |
| 26 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.4% | $51.1m | 2,654,781 | 38% | added |
| 27 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.3% | $48.2m | 1,200,000 | -11% | reduced |
| 28 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.3% | $45.0m | 7,859,648 | -11% | reduced |
| 29 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.2% | $41.2m | 450,000 | -36% | reduced |
| 30 | BCAX BICARA THERAPEUTICS INC | 1.1% | $38.3m | 2,426,657 | 0% | held | |
| 31 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 0.9% | $34.0m | 3,470,172 | 1% | added |
| 32 | CDTX CIDARA THERAPEUTICS INC | 0.8% | $28.7m | 300,000 | 20% | added | |
| 33 | QURE UNIQURE NV | 0.8% | $28.2m | 483,092 | – | new | |
| 34 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.7% | $25.3m | 2,000,000 | – | new |
| 35 | JBIO JADE BIOSCIENCES INC | 0.5% | $19.7m | 2,279,892 | -9% | reduced | |
| 36 | RAPT RAPT THERAPEUTICS INC | 0.5% | $19.4m | 751,422 | 0% | held | |
| 37 | GHRS GH RESEARCH PLC | 0.5% | $17.9m | 1,250,000 | -38% | reduced | |
| 38 | BRD1EUR MIND MEDICINE MINDMED INC | 0.5% | $17.7m | 1,500,000 | -40% | reduced | |
| 39 | ENGENE HOLDINGS INC | 0.4% | $15.3m | 2,239,353 | -51% | reduced | |
| 40 | GMAB GENMAB A/S | Healthcare | 0.4% | $14.8m | 481,267 | – | new |
| 41 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.3% | $12.2m | 1,454,562 | – | new |
| 42 | CNTX CONTEXT THERAPEUTICS INC | 0.2% | $7.2m | 7,419,355 | 0% | held | |
| 43 | IMA IMAGENEBIO INC | 0.2% | $7.2m | 878,516 | – | new | |
| 44 | XNCR XENCOR INC | Healthcare | 0.2% | $6.4m | 549,439 | 0% | held |
| 45 | HELP CYBIN INC | 0.2% | $5.9m | 1,000,000 | -35% | reduced | |
| 46 | CRMD CORMEDIX INC | 0.2% | $5.8m | 500,000 | – | new | |
| 47 | PEPG PEPGEN INC | Healthcare | 0.2% | $5.5m | 1,200,000 | – | new |
| 48 | CBIO CRESCENT BIOPHARMA INC. | 0.2% | $5.4m | 453,686 | 0% | held | |
| 49 | ALGS ALIGOS THERAPEUTICS INC | 0.1% | $4.4m | 444,110 | 0% | held | |
| 50 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.1% | $4.2m | 2,568,613 | -85% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.